Takeda Charter Oak Partner

Connecticut Oncology Association

Home

About Us

Officers

Contact Us

Events

Corporate Partners

Membership

Member Application

Resources

Members Only

Corporate Sites

https://www.takeda.com/

Health Care Professionals site

Contact in CT:

Important News and Information

U.S. FDA Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment Option for Patients Diagnosed with Rare and Serious Form of Lung Cancer

05/22/2020

Takeda Announces U.S. FDA Breakthrough Therapy Designation for Mobocertinib (TAK-788) for the Treatment of NSCLC Patients with EGFR Exon 20 Insertion Mutations 04/27/2020

Connecticut Oncology Association (CtOA)

c/o Dawn Holcombe

33 Woodmar Circle
South Windsor, CT 06074
(860) 305-4510

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software